SCM
TMO icon

Sterling Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Sterling Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41M Sell
4,909
-133
-3% -$72.2K 0.05% 297
2025
Q4 		$2.92M Sell
5,042
-709
-12% -$401K 0.05% 291
2025
Q3 		$2.79M Sell
5,751
-593
-9% -$276K 0.04% 291
2025
Q2 		$2.57M Buy
6,344
+1,368
+27% +$572K 0.04% 313
2025
Q1 		$2.48M Sell
4,976
-429
-8% -$232K 0.04% 302
2024
Q4 		$2.81M Sell
5,405
-642
-11% -$353K 0.04% 315
2024
Q3 		$3.74M Buy
+6,047
New +$3.58M 0.05% 266
2019
Q3 		$1.03M Buy
3,530
+30
+0.9% +$8.59K 0.01% 602
2019
Q2 		$1.03M Hold
3,500
– – 0.01% 569
2019
Q1 		$958K Sell
3,500
-1,006
-22% -$250K 0.01% 588
2018
Q4 		$1.01M Sell
4,506
-3,645
-45% -$855K 0.01% 533
2018
Q3 		$1.99M Sell
8,151
-33
-0.4% -$7.59K 0.02% 420
2018
Q2 		$1.7M Sell
8,184
-54
-0.7% -$11.5K 0.02% 448
2018
Q1 		$1.7M Sell
8,238
-31,155
-79% -$6.54M 0.02% 438
2017
Q4 		$7.48M Sell
39,393
-42
-0.1% -$8.05K 0.07% 217
2017
Q3 		$7.46M Sell
39,435
-25,320
-39% -$4.59M 0.07% 210
2017
Q2 		$11.3M Buy
64,755
+50,688
+360% +$8.51M 0.11% 166
2017
Q1 		$2.16M Sell
14,067
-27,685
-66% -$4.23M 0.02% 376
2016
Q4 		$5.89M Buy
41,752
+25,808
+162% +$3.8M 0.05% 224
2016
Q3 		$2.54M Sell
15,944
-3,013
-16% -$464K 0.02% 331
2016
Q2 		$2.8M Sell
18,957
-948
-5% -$140K 0.03% 323
2016
Q1 		$2.82M Buy
19,905
+8,477
+74% +$1.14M 0.03% 320
2015
Q4 		$1.62M Sell
11,428
-460
-4% -$61.4K 0.01% 432
2015
Q3 		$1.45M Buy
11,888
+6,456
+119% +$841K 0.01% 449
2015
Q2 		$704K Buy
+5,432
New +$708K 0.01% 526
2014
Q4 		– Sell
-1,719
Closed -$209K – 961
2014
Q3 		$209K Buy
+1,719
New +$209K ﹤0.01% 871
2013
Q4 		– Sell
-45,884
Closed -$4.23M – 825
2013
Q3 		$4.23M Buy
+45,884
New +$4.15M 0.05% 153

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sterling Capital Management's TMO Position: Q1 2026 in Review

Sterling Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 2.6% in Q1 2026, selling an estimated $72.2K and leaving 4,909 shares worth $2.41M. The position accounts for 0.05% of the portfolio, ranked #297.

Sterling Capital Management first reported a position in TMO in Q3 2013 and has held it in 27 quarters since. The position peaked at $11.3M in Q2 2017. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Sterling Capital Management held 4,909 shares of Thermo Fisher Scientific worth $2.41M as of Q1 2026.
  • Sterling Capital Management sold 133 Thermo Fisher Scientific shares in Q1 2026, an estimated $72.2K.
  • Thermo Fisher Scientific made up 0.05% of Sterling Capital Management's portfolio in Q1 2026, its #297 holding.
  • Sterling Capital Management first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 27 quarters since.
  • Sterling Capital Management's Thermo Fisher Scientific position peaked at $11.3M in Q2 2017.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.